Skip to main content
TipRanks
Go Ultimate75% OFF

Anthony Y. Sun Insider Profile

11 Followers

Anthony Y. Sun, President & CEO, Director at Zentalis Pharmaceuticals, holds 2.59M shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 26.32K shares in Hyperion DeFi (Ticker: HYPD), holds 23.88K shares in Aravive (Ticker: ARAV).

Anthony Y. Sun's Trading History

ZNTL
Zentalis Pharmaceuticals
Apr 05, 2022President & CEO, DirectorUninformative Sell1.05M$4.41M
HYPD
Hyperion DeFi
Nov 22, 2021DirectorUninformative Buy―$67.91K
ARAV
Aravive
Dec 22, 2017―Uninformative Buy―$955.20

You May Also Like

Anthony Y. Sun insider profile FAQ

What is the percentage of profitable transactions made by Anthony Y. Sun?
The percentage of profitable transactions made by Anthony Y. Sun is 33%.
What is the average return per transaction made by Anthony Y. Sun?
The average return per transaction made by Anthony Y. Sun is -2.40%.
What stocks does Anthony Y. Sun hold?
Anthony Y. Sun holds: ZNTL, ARAV, HYPD stocks.
What was Anthony Y. Sun’s latest transaction?
Anthony Y. Sun’s latest transaction was an Uninformative Sell of $1.05M.
What was Anthony Y. Sun's most profitable transaction?
Anthony Y. Sun’s most profitable transaction was an Informative Buy of ZNTL stock on November 25, 2020. The return on the trade was 68.30%.
What is Anthony Y. Sun's role in Zentalis Pharmaceuticals?
Anthony Y. Sun's role in Zentalis Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.